Proof of Concept study of the efficacy and tolerability of a 4-week treatment with F13640 in patients in whom the adaptation of opioid therapy of cancer pain has failed. A prospective, multinational, multicentre, randomised, double-blind, placebo-controlled study.
Phase of Trial: Phase II
Latest Information Update: 31 Aug 2013
At a glance
- Drugs Befiradol (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- 18 Aug 2011 This trial is recruiting in France, but has been discontinued in Hungary and Czech Republic.
- 18 Aug 2011 New trial record